Dr. R. Rukkumani

About
Research Area

Dr.R.Rukkumani has an excellent academic record and received University Ranks throughout her studies. She has published 93 papers (h index 31 & i10 index 61) and has completed 6 projects from the government of India. Her research focuses on drug designing, cancer-targeted therapy, affordable 3D cultures, and diagnostics. She has received 20+ awards and is a sought-after speaker. She possesses holistic experience in both academia and industry and has worked for Novartis, Hyderabad University and Madras University. She is a passionate researcher aiming to find a complete cancer cure.

  • Professor

+91-413-2654-537

ruks2k2@pondiuni.ac.in

0 years
Teaching Experience
0
Research (Guided & On-roll)
0
Projects (Completed & On-going)
0
Publications

Notable & Recent Publications

Dutta D, Pajaniradje S, Nair AS, Chandramohan S, Bhat SA, Manikandan E, Rukkumani R*. An in-vitro study of active targeting & anti-cancer effect of folic acid conjugated chitosan encapsulated indole curcumin analogue nanoparticles. Int J Biol Macromol. 4;282 (Pt 5):136990. (2024) I.F -7.7

Poornima K, Arul Prakash F, Muddasarul H, Srividya S, Mohamed AE, Vishnu Priya V, Mohamed ES, Saad MA, Abdulrahman BAH, Krishna Mohan S, Mony U, Rukkumani R*. Implications of three-dimensional cell culture in cancer therapeutic research, Front. Oncol, 12: 1-12 (2022).I.F –6.122

Neena Y, Arul Prakash F, Priya VV, Patil S, Mustaq S, Khan SS, Alzahrani KJ, Banjer, HJ, Mohan SK, Mony U and Rukkumani, R*, Polysaccharide-Drug Conjugates: A Tool for Enhanced Cancer Therapy. Polymers, 14(5): 950 (2022) I.F–5.063

Sufi SA, Hoda M, Sankar P, Mukherjee V, Mohane Coumar S, Rukkumani R*. Enhanced drug retention, sustained release, and anti-cancer potential of curcumin and indole-curcumin analog-loaded polysorbate 80-stabilizied PLGA nanoparticles in colon cancer cell line SW480. International Journal of Pharmaceutics, 588:119738, (2020) I.F 6.51

Sufi SA, Pajaniradje S, Mukherjee V, Rukkumani R*. Redox nano–architectures: Perspectives and Implications in Diagnosis and Treatment of Human Diseases, Antioxidant Redox Signalling, 30(5):762-785. (2019) I.F. 9.009